Advertisement
U.S. Markets closed

Vicore Pharma Holding AB (publ) (VICO.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
8.62-0.55 (-6.00%)
At close: 05:29PM CEST
Currency in SEK

Valuation Measures4

Market Cap (intraday) 1.93B
Enterprise Value 1.67B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.44
Price/Book (mrq)4.43
Enterprise Value/Revenue 15.99
Enterprise Value/EBITDA -4.30

Trading Information

Stock Price History

Beta (5Y Monthly) 0.68
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 324.10
52 Week Low 36.92
50-Day Moving Average 311.28
200-Day Moving Average 315.70

Share Statistics

Avg Vol (3 month) 3857.13k
Avg Vol (10 day) 31.56M
Shares Outstanding 5223.47M
Implied Shares Outstanding 6N/A
Float 898.65M
% Held by Insiders 16.83%
% Held by Institutions 128.56%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -191.92%
Operating Margin (ttm)-213.73%

Management Effectiveness

Return on Assets (ttm)-34.01%
Return on Equity (ttm)-54.29%

Income Statement

Revenue (ttm)104.24M
Revenue Per Share (ttm)0.94
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -219.44M
Net Income Avi to Common (ttm)-200.06M
Diluted EPS (ttm)-1.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)466.44M
Total Cash Per Share (mrq)4.18
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.98
Book Value Per Share (mrq)3.89

Cash Flow Statement

Operating Cash Flow (ttm)-129.3M
Levered Free Cash Flow (ttm)-118.87M